Skip to content

Tenofovir/ddI: is CD4 cell loss on treatment linked to this combination?

Early virologic failure with ddI/tenofovir plus nevirapine or efavirenz

Kaletra effective and well tolerated in PI-experienced patients

Failure of three main classes of antiretrovirals present in 12% of EuroSIDA cohort

Roche will not go ahead with nelfinavir 625mg formulation in Europe: cites production problems

Higher than expected incidence of HIV found in injecting drug users in London

Keeping track of patients and drugs in rural Haiti: electronic system is practical

HIV protease inhibitors may also check malaria

HIV-positive former IDUs have poorer immune response to HAART